Results. Survival was associated with age, medical factors and transplantation. The hazard ratio (HR) of death for patients on dialysis compared to transplant recipients was 4.6 (95% CI: 2.9-7.2). The survival analysis stratified by PS was similar to the multivariate Cox model. The survival benefit of transplantation over dialysis persisted among elderly patients [HR: 4.6 (95% CI: 2.2-9.7)]. Conclusions. In a French community-based network, after taking into account comorbidities, transplantation was associated with longer survival even among elderly patients. Age per se should not therefore be considered as a contraindication to renal transplantation. However, elderly patients should be evaluated carefully before registration on the list. Medical guidelines should put forward a standard set of criteria for access to renal transplantation.
Introduction
In the general population, due to ageing, incidence and prevalence of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) are steadily increasing [1, 2] . In addition, the proportion of patients >60 receiving kidney transplantation has increased substantially over the past decade [3, 4] . Concurrently, it was shown that kidney transplantation was associated with longer survival [5] [6] [7] [8] [9] [10] [11] [12] [13] , even if survival benefits of transplantation, compared to dialysis, in elderly patients are still debated [3, [14] [15] [16] [17] . However, for several reasons these findings may not be extrapolated to the French population. First of all, compared with early studies, continued improvement, in immunosuppressive protocols as well as surgical and dialysis techniques, has considerably modified patient morbidity and mortality.
Secondly, most of the above findings come from studies conducted in the USA, where waiting time before receiving kidney transplantation and mortality of wait-listed on-dialysis patients are largely different from other countries. Only a few reports have studied the survival of ESRD patients in Europe; one population-based study in Scotland [10] and two single-centre studies in Sweden [9] and Germany [8] .
Finally, recent comparative studies suggested significant differences on country-specific selection for and outcomes of kidney transplantation [18, 19] . For instance, the relative risk of receiving a kidney transplant ranged from 0.23 for Lombardy to 3.86 for Norway [18] . Moreover, the twostep process, i.e. first, selection for wait-list, and second, for kidney transplantation, should influence the statistical methodology of studies [5, 20, 21] . For all of the above reasons, even the methods used by other studies may not be applicable to French data.
Last but not least, France has been historically viewed as a country where dialysis performance was good [22] . However, until now, no study focused on the impact of kidney transplantation on survival of dialysed patients in a French population.
After a study on determinants of access to the waiting list [23] , we performed a population-based study within a French network of care to ascertain (1) survival of transplanted and dialysed patients in a French region and (2) whether transplantation offers a survival advantage over dialysis in older patients (age ≥60 years).
Subjects and methods

Organization of care for chronic kidney disease in the Lorraine region
The NEPHROLOR network of care was set up in 2002, combining the nine public, two private not-for-profit and two private for-profit facilities operating dialysis units in Lorraine. In Lorraine, as in most French regions, renal transplantation is performed within the University nephrology department which is the only transplant centre of the region. In France, the rules regarding organ allocation are established by the Agence de la Biomédecine [24] .
Study population
The crude incidence of ESRD in Lorraine was 149.5 per million inhabitants in 2006, and 68.2% of the patients were >65 years old. For the present study, we included all adult patients living in Lorraine and starting RRT (dialysis or pre-emptive transplantation) between 1 July 1997 and 30 June 2003. As the oldest patient registered on the waiting list was 78 years old, we did not include patients >80 years on the first day of RRT in the analysis. Using these criteria, 1495 patients were included and followed to death or last visit or 31 December 2005.
In order to identify all patients placed on the waiting list and transplanted, the list of patients registered on the French national waiting list was extracted from the CRISTAL database of the Agence de la Biomédecine; the list of transplanted patients was extracted from the database of the kidney transplantation unit.
Data collection
For each inclusion of a new patient in the NEPHROLOR database, a standardized form is prospectively filled out when starting RRT [1, 25] . Three categories of variables possibly related to registration on the waiting list and to survival were studied.
The first included social and demographic data: age and gender. The distance between the patient's residence and the department performing transplantation was calculated in kilometres. In France, legal regulations prohibit considering ethnic differences in the French ESRD registry, and descriptions about income or education were not available [1] .
The second category comprised clinical and biological data at first RRT: existence of diabetes, cardiovascular disease (coronary artery disease, peripheral vascular disease, congestive heart failure and cerebrovascular disease), respiratory disease, hepatic disease, psychiatric disorder (severe depression or other psychiatric disorder) and past history of malignancy. Patients who were confined to a wheelchair or were bedridden were considered to have physical impairment of ambulation. Body mass index (BMI) was calculated according to the formula weight (kg)/square of height (m) and categorized into <20, 20-24.99, ≥25 and serum albumin in <3 g/dl, 3-3.49 and ≥3.5.
The third category included data related to medical follow-up in the NEPHROLOR network: date of first RRT, urgent versus planned first dialysis session, ownership of nephrology facility where the first RRT was performed: public or private, date of registration on the waiting list for registered patients and date of transplantation for transplanted patients. We also took into account the effect of a medical follow-up in the unit performing transplantation versus 12 other facilities without transplantation activity.
Statistical analyses
Death was the clinical endpoint. Patient survival was assessed from the date of first RRT until death, end of study (December 2005) or last follow-up available. Univariate Cox survival analyses were performed to search for correlations between survival and initial demographic, clinical and biological variables and follow-up data. Kidney transplantation was modelled as a time-dependent covariate. Subsequently, multivariate Cox proportional hazards models were constructed using variables with a P-value < 0.2 in the univariate analyses. Results are reported as hazard ratios with 95% CI and P-values. Statistical significance was identified by a P-value < 0.05 (two-tailed). We performed an intention-to-treat analysis; the patients with graft failure did not drop from the analysis and contributed to the survival on transplantation.
As patients registered on the waiting list are younger and healthier than non-registered on-dialysis patients, a propensity score (PS) [23] was estimated to control nonrandom treatment assignment bias. This approach has been used also by Winkelmayer et al. for comparing mortality of patients on haemodialysis versus peritoneal dialysis [26] . This score was defined as the conditional probability of being registered on the kidney transplant waiting list, based on the subject's characteristics. Two patients with the same PS could have different values for specific covariates, but they had the same chance to be wait-listed. The PS was estimated using a multivariate logistic regression, modelling registration on the list as the dependent variable and the patient characteristics as the independent covariates (age, clinical and biological data: existence of diabetes, cardiovascular disease, respiratory disease, psychiatric disorder, past history of malignancy, physical impairment, BMI and follow-up data: urgent versus planned first dialysis session). The area under the ROC curve was used to assess the predictive validity of the logistic regression model. The patients were then classified into subgroups by PS tertile, and the balance of covariates between registered and non-registered patients of these subgroups was verified. Multivariate Cox analyses stratified by PS tertiles were then performed.
Finally, survival advantage of transplantation in two groups of subjects, younger patients (<60 years) and older patients (≥60 years), was studied by using univariate and multivariate Cox analyses.
Survival curves were generated using the Kaplan-Meier method. The differences in proportions and means were tested by χ 2 and t-test, respectively (or non-parametric tests when necessary). Statistical analyses were performed with the SAS software (version 9.1; SAS Institute Inc., Cary, NC, USA).
Results
Patients' characteristics
During the study period, 1495 adult patients aged 80 years or younger started RRT in the NEPHROLOR network. Their mean age was 62.5 ± 14.3 years. By the end of December 2005, 834 of them (55.8%) had died. No patient was lost to follow-up. Among 1495 patients, 369 (24.7%) were listed for a first transplant and 334 (22.3%) underwent renal transplantation, mostly with deceased donors (16 living donors). Thirty-three (8.9%) of 369 registered patients underwent pre-emptive transplantation (7 living donors). Among patients registered on the waiting list after their first RRT, the mean delay between dialysis start and registration was 1.3 months (median 8.4 months). The mean delay between registration on the waiting list and transplantation was 9.0 months (median 6.6 months). Ten wait-listed patients and 22 transplanted patients died during the study period.
Among the 1495 patients, 501 (33.5%) were <60 years old. Three hundred and six of them (61.1%) were registered on the waiting list and 280 (55.9%) underwent transplantation (16 living donors) with a mean delay of 9.5 months between registration on the waiting list and transplantation (median 7.2). One hundred and twenty-nine of them (25.7%) died during the study period (9 on the waiting list, 15 after transplantation).
Nine hundred and ninety-four patients (66.5%) were aged 60 years or older. Among them, 63 (6.3%) were put on the waiting list and 54 (5.4%) received a transplant. The mean delay between registration on the list and transplantation was 6.6 months (median 4.4). Of the 994 elderly patients, 705 (70.9%) died during the study period (1 on the waiting list, 7 after transplantation).
Among transplant recipients, 3 patients died during the first month following transplantation, 7 patients between 31 and 365 days after grafting and 12 others beyond 365 days. In the transplant group, 36.4% of deaths were due to infection, 27.3% to malignancy and 28.2% to cardiac disease, while in the dialysis group 27.9% of deaths were due to cardiac disease, 16.3% to vascular disease, 11.8% to infection, 10.6% to malignancy and 10.4% to cachexia. Table 1 presents the characteristics of the whole population at first RRT and a comparison of younger patients (<60 years) with older ones (≥60 years). Except for physical impairment and psychiatric disorder, all comorbidities were more frequently observed in patients ≥60 years. Serum albumin level was higher in patients <60 years while BMI was lower.
Except for medical follow-up in the nephrology department performing transplantation, non-medical characteristics of patients <60 years were not significantly different from those ≥60 years. We also looked at the calendar period of the first RRT, which was not significantly different between age subgroups. Patients <60 years were more likely to have a planned first dialysis session.
The PS of registration on the waiting list was estimated by a logistic regression model. The area under the ROC curve was 0.92 (IC 95%: 0.90-0.94). Table 2 shows the baseline characteristics of registered and non-registered patients, within tertile of PS for registration on the list. Except for the highest tertile of PS, patients registered on the list differed little from non-registered ones within each tertile of PS. Within the highest tertile, the registered patients were younger than non-registered ones and were less likely to have cardiovascular disease and diabetes. The blood albumin level was higher, while BMI was lower among registered patients.
Overall survival analysis Table 3 shows the factors associated with mortality. In univariate analyses, all comorbidities, older age, low serum albumin level and urgent first dialysis session were significantly associated with higher risk of death. Compared with transplant recipients, patients on dialysis had an increased risk of death. Gender and calendar period of the first RRT were not significantly associated with mortality.
In multivariate Cox analysis, except for respiratory disease, all comorbidities were associated with higher death risk. Patients having old age, low serum albumin level and urgent first dialysis session were more likely to die. Transplantation was also independently associated with mortality. In other words, after adjusting for age, comorbidities, BMI and serum albumin level, the relative risk of death for patients on dialysis compared to transplant recipients was 4.6 (95% CI: 2.9-7.2). Likelihood of death was higher for patients with missing BMI data than those with BMI ≥25.
As shown in Table 3 , there was not a notable difference between the results of survival analysis stratified by PS and the results of the multivariate Cox model. 
Survival analysis by age subgroups
The survival curves of dialysis and transplant recipients are shown in Figure 1 . The 3-year survival rates of dialysis and transplanted patients <60 years old were 63% and 98%, respectively. The 3-year survival rates of dialysis and transplanted patients aged 60 years or more were 42% and 94%, respectively. Table 4 presents the factors associated with mortality in patients <60 years old. In univariate analyses, all comorbidities, low serum albumin level and urgent first dialysis session were associated with a significant increase in the risk of death. The relative risk of death was higher in dialysis patients compared to transplant recipients. In multivariate analysis, diabetes, past history of malignancy, respiratory disease, physical impairment and psychiatric disorder were independently associated with risk of death, while cardiovascular disease and urgent first dialysis session were not.
The relative risk of death for dialysis patients compared to transplant recipients was 4.5 (95% CI: 2.5-8.1). Patients with missing BMI data were 2.7 times more likely to die compared to those having BMI ≥25. Table 5 shows the covariates associated with risk of death in the subgroup of patients ≥60 years old. In univariate analyses, except for past history of malignancy, all comorbidities were associated with increased likelihood of death. Low serum albumin level and urgent first dialysis session were also associated with high relative risk of death. Compared to transplant recipients, patients on dialysis were more likely to die. In multivariate analysis, cardiovascular disease, diabetes, past history of malignancy, physical impairment, psychiatric disorder, low serum albumin level and urgent first dialysis session were independently associated with increased relative risk of death. Patients with missing BMI data were more likely to die compared to those having BMI ≥25. Compared to transplant recipients, the relative Fig. 1 . Kaplan-Meier graphs of patients' survival: transplant recipients aged <60 years old (blue curve), transplant recipients aged ≥60 years old (black curve), on dialysis patients aged <60 years old (red curve) and on dialysis patients aged ≥60 years old (green curve).
risk of mortality among patients on dialysis was 4.6 (95% CI: 2.2-9.7). Regardless of age subgroup, neither gender nor calendar period of the first RRT was associated with relative risk of mortality.
Discussion
Our 9-year population-based study shows a survival advantage of transplantation over dialysis, in Lorraine, after adjusting for age, comorbidities, serum albumin and BMI levels. The analyses using the PS of registration on the list, which allowed better control of selection bias, confirmed these findings. Moreover, the beneficial effect of transplantation persisted in older patients (≥60 years old).
We used a prospective cohort database that involved 100% of Lorraine inhabitants starting RRT in the NEPHROLOR network, and two independent databases to identify patients registered on the waiting list and those transplanted. No patient was lost to follow-up in our study. Therefore, our data can be assumed to be highly reliable and complete. Moreover, in contrast with previous reports from the USA, Canada, Australia and Scotland [5, 7, 27, 28] , our data enabled taking into account all the major comorbidities, BMI and serum albumin level.
Our findings confirm previous reports. In the present study, the transplant recipients had 78% lower HR of death compared to the dialysis patients. These results are similar to the 64-75% lower HR of death, observed in the USA, Canada, Germany, Sweden, Australia and Scotland [5] [6] [7] [8] [9] [10] 27] . These studies compared the survival of transplant recipients with dialysis wait-listed patients. While the present study compared transplanted patients with the general dialysis population, and because of a selection bias, mortality of general dialysis patients was higher than dialysis patients waiting on the list. Direct comparison of international results is therefore not feasible. However, a recent study, comparing the survival of transplanted patients with those on the waiting list and also with all dialysis patients, reported a survival benefit from transplantation regardless of gender, age and comorbidities [12] . The methodologies and statistical analyses used in early studies comparing survival of transplant recipients with dialysis patients were not appropriate. No account was taken of the selection bias of patients registered on the waiting list or for time-to-treatment bias [5] . Wolfe et al. [5] suggested a method to reduce these biases. They studied the patients registered on the waiting list, compared transplant recipients with wait-listed dialysis patients and showed a survival advantage of transplantation over dialysis. Several studies, using the same method, demonstrated that survival of transplant recipients exceeds survival of dialysis patients. However, this method of comparison cannot remove the selection bias completely. As shown by the same studies, the proportion of wait-listed patients who undergo transplantation varies between 46% in Australia and New Zealand [7] , 50% in the USA [5, 27] , 62% in Ontario [6] and 63% in Scotland [10] . Two European single-centre reports showed that 47% [8] and 70% [9] of the registered patients underwent transplantation. The patients who received a transplant were younger and had fewer comorbidities compared to wait-listed dialysis patients. These results confirm that, even if the subgroup of the transplant candidates is more homogenous than the total population of patients treated for ESRD, the choice of transplant recipients leads to a second selection among patients registered on the waiting list.
The present study demonstrates that the practice patterns of NEPHROLOR health professionals seem different from other centres. In Lorraine, 24.7% of the patients were put on the waiting list (versus 38% in Scotland [10] or 50% in Australia [7] ), but 90% of the wait-listed patients underwent transplantation (versus 63% in Scotland [10] or 46% in Australia [7] ). These results suggest that the selection criteria of the potential transplant recipients are more restrictive in Lorraine. But unlike the above-mentioned studies, access to transplantation after registration on the list in Lorraine was not limited by age or comorbidities. It was associated with blood group, immunization degree and one non-medical factor: medical follow-up at the nephrology unit performing transplantation (data not shown here). Furthermore, the mean time on the waiting list before receiving a transplant in Lorraine was substantially shorter than in other countries, 9.3 months in Lorraine versus 19.5 months in Australia [7] . For all of the above reasons, we could not apply the statistical method suggested by Wolfe et al. [5] to evaluate the survival advantage of transplantation over dialysis in Lorraine. We studied the survival of all patients beginning RRT. However, to reduce the selection bias of transplant candidates, the PS of registration on the list was estimated using a logistic regression model. The variables included in the model were associated with the survival and also with the probability of being registered on the waiting list. As argued by some authors [21] , we did not include in the PS the variables not associated with the survival but only related to registration on the waiting list. Then, we performed the survival analyses were stratified by PS tertiles. As previously demonstrated [21, 29] , analyses stratified by the PS tertiles yield results not different from the conventional multivariate Cox model method.
After registration on the list, 86% of patients ≥60 years old underwent transplantation in Lorraine. This proportion was 39% in Australia [17] and Scotland [28] . This study confirms that transplantation is beneficial for older patients. After adjusting for comorbidities, serum albumin and BMI, elderly transplant recipients had a 78% lower risk of death compared with patients on dialysis. The similar results were reported by Johnson et al. [17] in Australia, 76% decrease in the mortality risk for transplanted patients (>60 years old) compared to those on the waiting list. While Rao et al. [3] showed that elderly recipients (>70 years old) had a 41% lower risk of death compared to wait-listed candidates. This difference could be due to differences in study design. These findings are especially important given the growing number of elderly patients requiring RRT worldwide. Today, as both RRT patients and deceased kidney donors are getting older and older, more and more RRT elderly in good condition could benefit from kidney transplantation. The mean delay between registration on the list and transplantation was significantly longer in patients <60 years old compared to older ones, 9.8 and 6.6 months, respectively, (P = 0.0044). This probably reflects the more expanded donor-recipient matching criteria used for older recipients.
Our study has some limitations. The PS was estimated using measured data and it cannot control for unmeasured or imperfectly measured variables. Therefore, residual bias cannot be excluded [20] . Another bias in this intentionto-treat analysis may exist; transplant recipients did not drop from the analysis and contributed to the survival on transplantation even if the transplantation failed.
In conclusion, the present study demonstrated the survival advantage of transplantation over dialysis in the NEPHROLOR network. The survival benefit of transplantation was evident regardless of age and after taking into account for comorbidities and medical conditions. These results should encourage nephrologists to extend their selection criteria to older patients with good medical condition. Age per se should not constitute a barrier against registration on the list, and elderly patients should have broader access to transplantation. However, with the current scarcity of organs, it is sometimes difficult to justify the use of a donor kidney for elderly patients. Giessing et al. showed that kidneys from deceased donors ≥75 years old can be transplanted safely into recipients aged ≥65 years old if similar donor criteria and local allocation practices are used [30] . In France, transplantation with an expanded criteria donor (ECD) kidney in elderly patients was associated with higher survival rates than remaining on the waiting list [4] . So, 'old-for-old' renal transplantation could be an effective approach to expanding the donor pool while maximizing graft survival in older recipients [31, 32] .
